Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$605M |
| 2 |
American Tower
AMT
|
+$352M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$347M |
| 4 |
TJX Companies
TJX
|
+$309M |
| 5 |
ExxonMobil
XOM
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$924M |
| 2 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$617M |
| 3 |
United Parcel Service
UPS
|
+$546M |
| 4 |
Qualcomm
QCOM
|
+$540M |
| 5 |
Eaton
ETN
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.22% |
| 2 | Financials | 10.48% |
| 3 | Healthcare | 9.58% |
| 4 | Industrials | 8.26% |
| 5 | Consumer Discretionary | 7.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Sutro Biopharma
STRO
$415M
| $532K | ﹤0.01% |
18,140
+3,239
| +22% | +$128K |
|
3327
Home Bancorp
HBCP
$564M
| $526K | ﹤0.01% |
13,153
| – | – |
|
3328
WisdomTree US LargeCap Fund
EPS
$1.64B
| $526K | ﹤0.01% |
9,242
+66
| +0.7% | +$3.64K |
|
|
MYD
3329
DELISTED
BlackRock MuniYield Fund
MYD
| $525K | ﹤0.01% |
48,425
-1,905
| -4% | -$20.5K |
|
|
NBH
3330
Neuberger Municipal Fund Inc
NBH
$302M
| $525K | ﹤0.01% |
49,181
-10,813
| -18% | -$111K |
|
|
ETB
3331
Eaton Vance Tax-Managed Buy-Write Income Fund
ETB
$461M
| $525K | ﹤0.01% |
37,185
+4,432
| +14% | +$60.4K |
|
3332
Mirum Pharmaceuticals
MIRM
$5.99B
| $523K | ﹤0.01% |
15,307
-3,720
| -20% | -$97.5K |
|
|
PDM
3333
Piedmont Realty Trust
PDM
$1.17B
| $523K | ﹤0.01% |
72,171
-784
| -1% | -$5.45K |
|
3334
Recursion Pharmaceuticals
RXRX
$1.8B
| $518K | ﹤0.01% |
69,133
-11,481
| -14% | -$100K |
|
3335
VanEck Video Gaming and eSports ETF
ESPO
$258M
| $518K | ﹤0.01% |
7,737
-14
| -0.2% | -$893 |
|
3336
Corbus Pharmaceuticals
CRBP
$184M
| $516K | ﹤0.01% |
+11,414
| New | +$480K |
|
3337
Beazer Homes USA
BZH
$874M
| $516K | ﹤0.01% |
18,787
+3,452
| +23% | +$97.9K |
|
3338
Quest Resource Holding
QRHC
$29.3M
| $512K | ﹤0.01% |
58,172
-26,540
| -31% | -$245K |
|
3339
BlackRock Income Trust
BKT
$340M
| $504K | ﹤0.01% |
42,269
-3,945
| -9% | -$45.7K |
|
3340
Nuveen Core Equity Alpha Fund
JCE
$290M
| $503K | ﹤0.01% |
33,515
+394
| +1% | +$5.56K |
|
3341
Invesco S&P 500 BuyWrite ETF
PBP
$362M
| $502K | ﹤0.01% |
22,635
-2,662
| -11% | -$59K |
|
3342
Royce Value Trust
RVT
$2.3B
| $497K | ﹤0.01% |
+34,357
| New | +$500K |
|
3343
Smith & Nephew
SNN
$12.6B
| $496K | ﹤0.01% |
20,003
-1,860
| -9% | -$46.4K |
|
3344
Xeris Biopharma Holdings
XERS
$1.53B
| $495K | ﹤0.01% |
219,906
-733,330
| -77% | -$1.48M |
|
3345
OraSure Technologies
OSUR
$268M
| $493K | ﹤0.01% |
115,702
-149,215
| -56% | -$759K |
|
3346
Schwab Fundamental International Small Company Index ETF
FNDC
$3.15B
| $493K | ﹤0.01% |
14,177
+482
| +4% | +$17K |
|
3347
Coursera
COUR
$1.5B
| $493K | ﹤0.01% |
68,813
-24,472
| -26% | -$233K |
|
3348
Grab
GRAB
$15.3B
| $492K | ﹤0.01% |
138,700
+84,377
| +155% | +$296K |
|
|
RFI
3349
Cohen & Steers Total Return Realty Fund
RFI
$304M
| $492K | ﹤0.01% |
42,577
+302
| +0.7% | +$3.42K |
|
3350
Carter Bankshares
CARE
$709M
| $488K | ﹤0.01% |
32,270
| – | – |
|
Similar funds
Ameriprise's Q2 2024 Portfolio in Review
As of Q2 2024, Ameriprise held 3,986 positions worth $370B, up 1.7% from $363B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Ameriprise's Q2 2024 filing shows 147 new, 1,504 increased, 2,054 reduced and 132 closed positions. Its largest new stake was GE Vernova: 483,715 shares worth $83M. The largest sale was iShares Russell 1000 Growth ETF, an estimated $924M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q2 2024 buy was GE Vernova: 483,715 shares worth $83M.
- Ameriprise added most to Apple in Q2 2024, an estimated $605M increase.
- Ameriprise's biggest Q2 2024 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $924M.
- Ameriprise fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $313M.
- Ameriprise's ten largest holdings make up 20% of its $370B portfolio in Q2 2024.
- Ameriprise opened 147 new positions and closed 132 in Q2 2024.
- Ameriprise's portfolio value rose 1.7% quarter-over-quarter to $370B.
Based on Ameriprise's 13F filing for Q2 2024, filed 14 Aug 2024.